Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those receiving two other treatments as part of the clinical trial, the National Institutes of Health announced yesterday. As a result, all future participants in the clinical trial will receive REGN-EB3 or mAb114, the two drugs that increased survival, the agency said. NIH is helping to fund the study, carried out by an international research consortium coordinated by the World Health Organization and monitored by an independent Data and Safety Monitoring Board. “While the final analysis of the data can occur only after all the data are generated and collected (likely late September/early October 2019), the DSMB and the study leadership felt the preliminary analysis of the existing data was compelling enough to recommend and implement these changes in the trial immediately,” NIH said. “The complete results will be submitted for publication in the peer-reviewed medical literature as soon as possible.”

Related News Articles

Headline
The Centers for Disease Control and Prevention today joined the global public health community in marking the end of the Ebola outbreak in the Democratic…
Headline
With Ebola outbreaks in the Democratic Republic of the Congo and Guinea, the Centers for Disease Control and Prevention is reminding U.S. health care personnel…
Headline
Health officials in Guinea Sunday declared an Ebola outbreak in the nation’s southeastern N’Zerekore prefecture after confirming three cases in the rural…
Headline
The Centers for Disease Control and Prevention today joined the global public health community in marking the end of the Ebola outbreak in the Democratic…
Headline
The Food and Drug Administration Oct. 14 approved Inmazeb for treating Zaire ebolavirus infection in adult and pediatric patients. The drug is a mixture…
Headline
The Democratic Republic of the Congo has reported 100 confirmed or probable Ebola cases and 43 deaths in Equateur Province since June 1, the World Health…